Home › Inflammatory Bowel Disease › NCT07210580

Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease

Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease: A Hybrid Effectiveness-Implementation Study

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

Inclusion criteria for Veteran patients include:

* receiving IBD care at one of the four sites
* reporting an impaired IBD-specific HRQOL using the Short IBD Questionnaire (SIBDQ\<60, as used by others)
* willingness and ability to participate in study procedures

Clinic staff criteria:

* relevant clinic staff (gastroenterologists, advanced practice providers, nurses) involved in MBC in IBD at the four study sites (Ann Arbor, Atlanta, Houston, Portland).

Exclusion Criteria:

Veteran Patient Exclusion criteria:

* Presence of an ostomy or ileal-pouch anal anastomosis
* Severe comorbid medical condition that can confound PRO scores and treatment priorities (e.g., cancer, transplant).
* Exclusions can be readily determined from chart review and a baseline patient assessment

Clinic staff exclusion criteria:

* Clinic staff without any experience with MBC in IBD.

About the study

This research study is addressing issues related to Inflammatory bowel disease (IBD), which is a chronic autoimmune disorder that affects over 60,000 Veterans. With close monitoring and timely treatment adjustment, the investigators can stop the natural progression of IBD, improving health-related quality of life (HRQOL) and reducing flares and hospitalizations. However, it is difficult to closely monitor Veterans with IBD between clinic visits. There is a critical need for solutions that support close between visit monitoring of Veterans with IBD. The Measurement-Based Care (MBC) for IBD study will take a systematic approach to collect, share, and act on patient reported outcome (PRO) data that can be used to achieve close monitoring. MBC supports patients' in managing their condition and boosting their confidence in their ability to handle their symptoms and disease, and also supports care teams in early recognition of health issues. The investigators will work with both Veterans and their care teams to understand and assess this program so it can be a model for future initiatives.

What is being tested

• MBC-IBD Intervention (behavioral)
• Enhanced Treatment as Usual (E-TAU) (other)

Sponsor: VA Office of Research and Development · Participants: 250 · Started: Mar 9, 2026

Contact the study team

• Shirley Cohen-Mekelburg, MD MS · Phone: (734) 845-5082
• Nicolle Marinec, MPH · Phone: (734) 845-3653

Official record on ClinicalTrials.gov — NCT07210580

Locations in the U.S.

Conditions

• Inflammatory Bowel Disease

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.